Norges Bank’s BioLife Solutions BLFS Stock Holding History

Norges Bank’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-136,200	Closed	-$6.06M	–	2279
2021 Q2	$6.06M	Buy	+136,200	New	+$4.8M	﹤0.01%	1872

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Norges Bank's BLFS Position: Q3 2021 in Review

Norges Bank sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 136,200 shares — an estimated $6.06M sold.

Norges Bank first reported a position in BLFS in Q2 2021 and held it in 1 quarter. The position peaked at $6.06M in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

Norges Bank reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
Norges Bank sold 136,200 BioLife Solutions shares in Q3 2021, an estimated $6.06M.
Norges Bank first reported a position in BioLife Solutions in Q2 2021 and held it in 1 quarter.
Norges Bank's BioLife Solutions position peaked at $6.06M in Q2 2021.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.